16
Apr

Buoyed by the success of its PAH franchise, Switzerland’s Actelion says it has begun a Phase III study of its in-house drug ponesimod for multiple sclerosis.

…read more

Source: Actelion launches Phase III MS test for ponesimod

    

0 No comments